Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

XLO
Xilio Therapeutics, Inc.US flagNASDAQ Global Select
8.70
USD
+0.13
- -
57.20MMarket Cap

Xilio Therapeutics, Inc. (XLO) Stock Split History

Learn about Xilio Therapeutics, Inc.'s most recent 1-for-14 basis stock split on March 16, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Xilio Therapeutics, Inc.'s most recent stock split

Split Date: 2026-03-16
Split Ratio: 1:14
Price Before Split: $0.55
Price After Split: $0.04

Developer API

Get XLO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/XLO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 14.00 times fewer shares (a 1:14 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Xilio Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-03-161:14Yes$0.55$0.04

About Xilio Therapeutics, Inc.

Company overview and industry information

Xilio Therapeutics, Inc. (XLO) operates in the Biotechnology industry. The recent 1-for-14 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Xilio Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.